Loading the company…
Loading the company…
In the last ten years FDA made 0 decisions for Edap Technomed (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family. The latest was on 2001-02-12.
| Family | Decisions on record |
|---|---|
| Kidney stone management | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2001-02-12 | 510(k) | K003529 | SONOLITH PRAKTIS, ENDOUROLOGY TABLE PRAKTIS |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Edap Technomed.
In 2025, Edap Technomed reported engagement with 510 surgeons and other clinicians in the states MedaRep covers, worth $946K in consulting, speaking, meals and travel for its device products, the most in New York ($326K to 51). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New York ($326K, 51 engaged), California ($289K, 74 engaged), New Jersey ($57K, 54 engaged), Washington ($36K, 4 engaged), North Carolina ($35K, 9 engaged).